Researchers combine optical, x-ray tomo techniques to better ID breast cancer

Diagnostic Imaging | November 15 – Combining digital breast tomosynthesis and a laser-based technique called diffuse optical tomography, radiologists may be better able to distinguish malignant from benign lesions in the breast, according to a new study published in Radiology.

Diffuse optical tomography measures levels of hemoglobin concentration, oxygen saturation, and other cellular characteristics based on how light from a near-infrared laser is absorbed and scattered within tissue.

“Optical imaging provides information that is not available on the mammogram,” said Dr. Daniel Kopans, a professor of radiology and a senior radiologist in the breast imaging division at Massachusetts General Hospital. Kopans is leading the ongoing research with David Boas, Ph.D., an associate professor at Harvard.

Cancers tend to have higher concentrations of hemoglobin due to the nests of blood vessels that develop around them, and they tend to deoxygenate blood faster than normal tissues, he said. Unlike MRI, optical imaging does not require intravenous injection of a contrast agent to see metabolism of the tissues. Optical imaging’s drawback is that it is low in spatial resolution.

In their research, Kopans and colleagues combine digital breast tomosynthesis and optical imaging to evaluate the breast without moving the patient. “By not moving the breast between studies, we can use the high-resolution, three-dimensional information from (breast tomosynthesis) to ‘constrain’ the optical information,” he said. “This allows us to refine the optical information and make better use of it to help differentiate benign from malignant tissues.”

The study, which was funded by the National Institutes of Health, combined breast tomosynthesis and optical tomography to examine 189 breasts from 125 women with an average age of 56. Optical source and detector probes were attached to a breast tomo unit and, with the breast compressed, used to acquire optical data. The optical probes were then removed without altering the breast compression and a breast tomo scan was performed.

Of the 189 imaging studies, 138 were negative and 51 showed evidence of lesions. The researchers found 26 malignant and 25 benign lesions, which were confirmed on biopsy.

In the 26 malignant tumors, total hemoglobin concentration (HbT) was significantly greater than in the normal glandular tissue of the same breast. Solid benign lesions and cysts had significantly lower HbT contrast compared with the malignant lesions.

“By providing additional differentiation of malignant and benign lesions, combined optical and x-ray imaging could potentially reduce unnecessary biopsies,” said lead author Qianqian Fang, Ph.D., a radiology instructor at Harvard.


No Comments

Sorry, the comment form is closed at this time.